Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Revenue (2024)

Zentalis Pharmaceuticals has reported Revenue over the past 1 years, most recently at $26.9 million for Q4 2024.

  • Quarterly results put Revenue at $26.9 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $26.9 million (down 33.76% YoY), and the annual figure for FY2024 was $67.4 million, changed.
  • Revenue for Q4 2024 was $26.9 million at Zentalis Pharmaceuticals, down from $40.6 million in the prior quarter.
  • Over the last five years, Revenue for ZNTL hit a ceiling of $40.6 million in Q1 2024 and a floor of $26.9 million in Q4 2024.